<Page>

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549
                            -------------------------

                                    FORM 10-Q

                 /X/ QUARTERLY REPORT PURSUANT TO SECTION 13 OR
                  15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
                 FOR THE QUARTERLY PERIOD ENDED AUGUST 31, 2001

                 / / TRANSITION REPORT PURSUANT TO SECTION 12 OR
                  15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

                  FOR THE TRANSITION PERIOD FROM ____ TO ____.

                             COMMISSION FILE NUMBER:
                                    333-12929

                      WEIDER NUTRITION INTERNATIONAL, INC.
             (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)

              DELAWARE                                    87-0563574
     (STATE OR OTHER JURISDICTION                      (I.R.S. EMPLOYER
    OF INCORPORATION OR ORGANIZATION)                 IDENTIFICATION NO.)



         2002 SOUTH 5070 WEST
         SALT LAKE CITY, UTAH                             84104-4726
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)                  (ZIP CODE)

               Registrant's telephone number, including area code:
                                 (801) 975-5000
                                 --------------


Indicate by check mark whether the Registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the Registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. Yes X No__


The number of shares outstanding of the Registrant's common stock is 26,249,436
(as of October 5, 2001.)


<Page>


PART I.  FINANCIAL INFORMATION
ITEM 1.  FINANCIAL STATEMENTS
         WEIDER NUTRITION INTERNATIONAL, INC. AND SUBSIDIARIES
                      CONDENSED CONSOLIDATED BALANCE SHEETS
                    (DOLLARS IN THOUSANDS, EXCEPT SHARE DATA)
<Table>
<Caption>
                                                                       August 31,        May 31,
ASSETS                                                                    2001            2001
                                                                      -----------       ---------
                                                                      (unaudited)
<S>                                                                   <C>              <C>
Current assets:
  Cash and cash equivalents                                            $   2,603        $  2,293
  Receivables, net                                                        48,615          46,710
  Inventories                                                             54,391          56,028
  Prepaid expenses and other                                               2,174           3,171
  Deferred taxes                                                           6,486           6,486
                                                                       ---------        --------

         Total current assets                                            114,269         114,688
                                                                       ---------        --------

Property and equipment, net                                               36,276          37,658
                                                                       ---------        --------

Other assets:
  Intangible assets, net                                                  42,331          43,561
  Deposits and other assets                                                6,498           5,946
  Notes receivable related to
    stock performance units                                                4,227           4,227
  Deferred taxes                                                           2,809           2,992
                                                                       ---------        --------

         Total other assets                                               55,865          56,726
                                                                       ---------        --------

                  Total assets                                         $ 206,410        $209,072
                                                                       =========        ========
LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:
  Accounts payable                                                     $  30,364        $ 34,181
  Accrued expenses                                                        15,195          14,029
  Earnout amounts payable                                                  1,341           1,298
  Current portion of long-term debt                                       21,334          19,537
  Income taxes payable                                                       417             336
                                                                       ---------        --------

         Total current liabilities                                        68,651          69,381
                                                                       ---------        --------

Long-term debt                                                            53,398          53,891
                                                                       ---------        --------
Commitments and contingencies

Stockholders' equity:
  Preferred stock, par value $.01 per share; shares
    authorized-10,000,000; no shares issued and outstanding                   --              --
  Class A common stock, par value $.01 per share; shares
    authorized-50,000,000; shares issued and
    outstanding-10,562,004                                                   105             105
  Class B common stock, par value $.01 per share; shares
    authorized-25,000,000; shares issued and
    outstanding-15,687,432                                                   157             157
  Additional paid-in capital                                              86,897          86,897
  Other accumulated comprehensive loss                                    (5,967)         (5,864)
  Retained earnings                                                        3,169           4,505
                                                                       ---------        --------

         Total stockholders' equity                                       84,361          85,800
                                                                       ---------        --------

                  Total liabilities and stockholders' equity            $206,410        $209,072
                                                                       =========        ========
</Table>

            See notes to condensed consolidated financial statements.

                                       2
<Page>


              WEIDER NUTRITION INTERNATIONAL, INC. AND SUBSIDIARIES
                 CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                    (DOLLARS IN THOUSANDS, EXCEPT SHARE DATA)
                                   (UNAUDITED)
<Table>
<Caption>
                                                          Three Months Ended
                                                               August 31,
                                                     ---------------------------
                                                        2001              2000
                                                     ---------         ---------
<S>                                                 <C>               <C>
Net sales                                           $   87,154        $   91,210

Cost of goods sold                                      53,954            53,255
                                                     ---------         ---------

Gross profit                                            33,200            37,955
                                                     ---------         ---------

Operating expenses:
  Selling and marketing                                 23,072            25,663
  General and administrative                             6,707             7,994
  Research and development                               1,389             1,616
  Amortization of intangible assets                        791               757
  Litigation settlement                                     --            (3,571)
  Plant consolidation and transition                        --               648
                                                     ---------         ---------

         Total operating expenses                       31,959            33,107
                                                     ---------         ---------

Income from operations                                   1,241             4,848
                                                     ---------         ---------

Other income (expense):
  Interest income                                           28                40
  Interest expense                                      (2,218)           (2,498)
  Other                                                   (216)              (28)
                                                     ---------         ---------

         Total other expense, net                       (2,406)           (2,486)
                                                     ---------         ---------

Income before income taxes (benefit)                    (1,165)            2,362

Provision for income taxes (benefit)                      (813)              398
                                                     ---------         ---------

Net income (loss)                                   $     (352)       $    1,964
                                                    ==========        ==========
Weighted average shares outstanding:

  Basic                                             26,249,236        26,226,165
                                                    ==========        ==========

  Diluted                                           26,249,236        26,230,821
                                                    ==========        ==========
Net income (loss) per share:

  Basic                                             $    (0.01)       $     0.07
                                                    ==========        ==========
  Diluted                                           $    (0.01)       $     0.07
                                                    ==========        ==========

Comprehensive income (loss)                         $     (455)       $    1,936
                                                    ==========        ==========
</Table>

            See notes to condensed consolidated financial statements.

                                       3
<Page>

              WEIDER NUTRITION INTERNATIONAL, INC. AND SUBSIDIARIES
                 CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                             (DOLLARS IN THOUSANDS)
                                   (UNAUDITED)

<Table>
<Caption>
                                                                 Three Months Ended
                                                                      August 31,
                                                              -------------------------
                                                                 2001            2000
                                                              ---------        --------
<S>                                                          <C>               <C>
Cash flows from operating activities:
  Net income (loss)                                           $  (352)          $ 1,964
  Adjustments to reconcile net income (loss) to net
    cash provided by (used in) operating activities:
         Provision for (recovery of) bad debts                   (330)              231
         Deferred taxes                                           184               344
         Depreciation and amortization                          2,515             3,141
         Amortization of original issue discount                  147                98
  Changes in operating assets and liabilities:
         Receivables                                           (1,575)            2,653
         Inventories                                            1,637            (3,655)
         Prepaid expenses and other                               997              (512)
         Deposits and other assets                                (32)           (2,221)
         Accounts payable                                      (3,818)             (788)
         Accrued expenses                                       1,077            (3,319)
                                                              -------           -------
           Net cash provided by (used in)
             operating activities                                 450            (2,064)
                                                              -------           -------
Cash flows from investing activities:
  Purchase of intangibles                                         (41)              (30)
  Purchase of property and equipment                             (522)           (1,277)
                                                              -------           -------

           Net cash used in investing activities                 (563)           (1,307)
                                                              -------           -------

Cash flows from financing activities:
  Issuance of warrants/common stock                                --             3,524
  Dividends paid                                                 (984)             (938)
  Net change in revolving line-of-credit                        4,114           (41,321)
  Proceeds from debt                                            1,905            41,933
  Payments on debt                                             (4,594)             (257)
                                                              -------           -------
           Net cash provided by
            financing activities                                  441             2,941
                                                              -------           -------

Effect of exchange rate changes on cash                           (18)              (47)
                                                              -------           -------

Increase (decrease) in cash and cash equivalents                  310              (477)

Cash and cash equivalents, beginning of period                  2,293             3,011
                                                              -------           -------

Cash and cash equivalents, end of period                      $ 2,603           $ 2,534
                                                              =======           =======
</Table>

            See notes to condensed consolidated financial statements.


                                       4
<Page>


              WEIDER NUTRITION INTERNATIONAL, INC. AND SUBSIDIARIES

              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                             (DOLLARS IN THOUSANDS)
                                   (UNAUDITED)

1.   BASIS OF PRESENTATION AND OTHER MATTERS

     The accompanying unaudited interim consolidated financial statements
("interim financial statements") do not include all disclosures provided in the
annual consolidated financial statements. These interim financial statements
should be read in conjunction with the consolidated financial statements and the
footnotes thereto contained in the Weider Nutrition International, Inc. (the
"Company") Annual Report on Form 10-K for the year ended May 31, 2001 as filed
with the Securities and Exchange Commission. The May 31, 2001 consolidated
balance sheet was derived from audited financial statements, but all disclosures
required by generally accepted accounting principles are not provided in the
accompanying footnotes. The Company is a majority-owned subsidiary of Weider
Health and Fitness ("WHF").

     In the opinion of the Company, the accompanying interim financial
statements contain all adjustments (which are of a normal recurring nature)
necessary for a fair presentation of the Company's financial position and
results of operations. Certain prior period amounts have been reclassified to
conform with the current interim period presentation. The results of operations
and cash flows for any interim period are not necessarily indicative of the
results of operations and cash flows that the Company may achieve for any other
interim period or for the entire year.

2.   RECEIVABLES, NET

     Receivables consist of the following:

<Table>
<Caption>                                                     August 31,         May 31,
                                                                2001               2001
                                                              -------            -------

        <S>                                                  <C>               <C>
         Trade accounts                                       $55,805           $53,485
         Other                                                  1,213             1,066
                                                              -------           -------
                                                               57,018            54,551

         Less allowance for doubtful accounts
          and sales returns                                    (8,403)           (7,841)
                                                              -------           -------

                           Total                              $48,615           $46,710
                                                              =======           =======
3.   INVENTORIES

     Inventories consist of the following:
                                                              August 31,         May 31,
                                                                 2001             2001
                                                              ----------         -------

         Raw materials                                        $19,074           $21,159
         Work in process                                        2,309             1,273
         Finished goods                                        33,008            33,596
                                                              -------           -------

                           Total                              $54,391           $56,028
                                                              =======           =======
</Table>


                                       5
<Page>


              WEIDER NUTRITION INTERNATIONAL, INC. AND SUBSIDIARIES

       NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
                             (DOLLARS IN THOUSANDS)
                                   (UNAUDITED)

4.   INTANGIBLE ASSETS

     Intangible assets consist of the following:
<Table>
<Caption>
                                                              August 31,         May 31,
                                                                 2001             2001
                                                              ----------        --------
        <S>                                                  <C>               <C>
         Cost in excess of fair value
           of net assets acquired (goodwill)                  $50,959           $51,381
         Patents and trademarks                                10,636            10,679
         Noncompete agreements                                    184               184
                                                              -------           -------
                                                               61,779            62,244

         Less accumulated amortization                        (19,448)          (18,683)
                                                              -------           -------

                           Total                              $42,331           $43,561
                                                              =======           =======
</Table>

     See Note 8 regarding the recent issuance of Statement of Financial
     Accounting Standard ("SFAS") No. 142.

5.   OPERATING SEGMENTS

     The Company has two primary reportable segments. These segments are the
Company's U.S. based or domestic operations, and the Company's international
operations (primarily Germany). The Company has three primary divisions within
its domestic operations: mass market; health food store; and health club and
gym. The Company manufactures and markets nutritional products, including a
broad line of vitamins, joint-related and other nutraceuticals, and sports
nutrition supplements through its mass market division; a broad line of
vitamins, nutraceuticals and sports nutrition products through independent
distributors and a significant retailer in its health food store division; and a
broad line of sports nutrition products primarily through distributors in its
health club and gym division. The Company also manufactures and markets
nutritional and other products, including a broad line of sports nutrition
supplements and sportswear, together with certain other nutraceuticals within
its international operations.

     The accounting policies of these segments are the same as those described
in Note 1 to the consolidated financial statements in the Company's Annual
Report on Form 10-K. The Company evaluates the performance of its operating
segments based on actual and expected operating results of the respective
segments and/or divisions. Certain noncash and other expenses, and domestic
assets, are not allocated to the divisions within the domestic operating
segment.



                                       6
<Page>


              WEIDER NUTRITION INTERNATIONAL, INC. AND SUBSIDIARIES

       NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
                             (DOLLARS IN THOUSANDS)
                                   (UNAUDITED)

     Segment information for the three months ended August 31, 2001 and 2000,
respectively, are summarized as follows:

<Table>
<Caption>
                                                                               Income
                                                                               (Loss)
                                                                Net             From         Interest
                                                               Sales         Operations       Expense
                                                                -----        ----------      --------
   <S>                                                       <C>            <C>             <C>
2001:
  Domestic Operations:
    Mass market                                               $ 48,905       $  4,250        $    467
    Health food stores                                           3,556           (299)             56
    Health clubs and gyms                                        5,913           (370)             83
    Other                                                          740             47               8
    Unallocated                                                     --            539              --
                                                              --------       --------        --------
                                                                59,114          4,167             614

  International Operations                                      28,040         (2,926)          1,604
                                                              --------       --------        --------

                  Total                                       $ 87,154       $  1,241        $  2,218
                                                              ========       ========        ========

                                                                               Income
                                                                               (Loss)
                                                                Net             From         Interest
2000:                                                          Sales         Operations       Expense
                                                              --------       ----------      --------
  Domestic Operations:
    Mass market                                               $ 51,256       $  4,482        $    803
    Health food stores                                           6,406           (510)            157
    Health clubs and gyms                                        6,228             29             153
    Other                                                        1,139           (385)             21
    Unallocated                                                     --          2,923              --
                                                              --------       --------        --------
                                                                65,029          6,539           1,134

  International Operations                                      26,181         (1,691)          1,364
                                                              --------       --------        --------

                  Total                                       $ 91,210       $  4,848        $  2,498
                                                              ========       ========        ========

    Reconciliation of total assets for the reportable segments is as follows:
                                                              August 31,                 May 31,
                                                                2001                      2001
                                                              --------                  --------
  Total domestic assets                                       $190,364                  $191,040
  Total international assets                                    80,045                    79,127
  Eliminations                                                 (63,999)                  (61,095)
                                                              --------                  --------

                  Total                                       $206,410                  $209,072
                                                              ========                  ========
</Table>

     Capital expenditures for domestic and international operations amounted to
$0.4 million and $0.1 million, respectively, for the three months ended August
31, 2001, and $0.8 million and $0.5 million, respectively, for the three months
ended August 31, 2000.


                                       7
<Page>


              WEIDER NUTRITION INTERNATIONAL, INC. AND SUBSIDIARIES

        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS--(CONTINUED)
                    (DOLLARS IN THOUSANDS, EXCEPT SHARE DATA)
                                  (UNAUDITED)

6. SALES TO MAJOR CUSTOMERS

         The Company's two largest customers accounted for approximately
47% and 46%, respectively, of net sales for the three months ended
August 31, 2001 and 2000, respectively.  At August 31, 2001 and
May 31, 2001, amounts due from these customers represented approximately
37% and 44%, respectively, of total trade accounts receivable.

7.   CONTINGENCIES

     In March 2000, the Company was named as a defendant in Garret vs. Weider
Nutrition International, Inc. et al. filed in Kansas state court. The lawsuit
alleges that consumption of a product of the Company containing ephedrine caused
a Mr. Garrett to experience ventricular fibrillation leading to brain hypoxia.
The Company disputes the allegations and tendered that matter to its insurance
carrier which assumed defense of the matter. After over three weeks of trial, in
June 2001, a jury determined that Mr. Garrett was not entitled to any
compensation from the Company. The trial court subsequently denied plaintiffs'
motions for a new trial. In August 2001, the plaintiffs filed an appeal of the
matter. The Company is opposing the appeal.

     In December 2000, the Company was named as a defendant in Long v. Weider
Nutrition Group, Inc. et. al. filed in Delaware state court. The lawsuit alleges
that consumption of a product of the Company containing ephedrine caused a heart
attack resulting in the death of Mr. Long. The plaintiffs are seeking
unspecified monetary damages. The Company disputes the allegations and is
opposing the lawsuits. The Company has tendered the matter to its insurance
carrier which has assumed defense of the matter.

     In April 2001, the Company was named as a defendant in Garcia, Speeter,
Marotti, et. al. v. Metabolife International, Weider Nutrition International,
et. al. filed in Nevada state court. The lawsuit alleges that the various
plaintiffs were each separately caused injuries and damages after consuming
products containing ephedrine manufactured or sold by the various respective
defendants. The plaintiffs are seeking unspecified monetary damages. The Company
disputes the allegations and is opposing the lawsuits. The Company has tendered
the matter to its insurance carrier, which has assumed defense of the matter.

     The Company believes that, after taking into consideration the Company's
insurance coverage, such lawsuits, if successful, would not have a material
adverse effect on the Company's financial condition. However, one or more large
punitive damage awards, which are generally not covered by insurance, could have
a material adverse effect on the Company's financial condition. The Company
cannot assure you that it will not be subject to further private civil actions
with respect to its ephedrine products. Prior to September 1, 2001, the Company
maintained both primary and excess product liability insurance coverage
regarding its ephedrine products. Upon renewing the Company's comprehensive and
product liability insurance coverage, as of September 1, 2001, the Company
currently maintains primary but not excess product liability coverage regarding
its ephedrine products. No


                                       8
<Page>


              WEIDER NUTRITION INTERNATIONAL, INC. AND SUBSIDIARIES

        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS--(CONTINUED)
                    (DOLLARS IN THOUSANDS, EXCEPT SHARE DATA)
                                  (UNAUDITED)

assurance can be given that product liability insurance regarding ephedrine will
be adequate to cover liabilities or continue to be available at a reasonable
cost, if at all. The absence of excess product liability insurance regarding
ephedrine products may have an adverse impact on the Company's financial
condition or operating results in the event of a significant adverse decision
against the Company.

     From time to time, the Company is involved in other claims, legal actions
and governmental proceedings that arise from the Company's business operations.
Although ultimate liability cannot be determined at the present time, the
Company believes that any liability resulting from these matters, if any, after
taking into consideration the Company's insurance coverage, will not have a
material adverse effect on the Company's financial position or cash flows.

8.   RECENTLY ISSUED ACCOUNTING STANDARDS

     In May 2000, and April 2001, the Financial Accounting Standards Board
("FASB") issued Emerging Issues Task Force ("EITF") No.00-14, and No. 00-25,
respectively. These EITF's address the recognition, measurement and income
statement classification for certain sales incentives or consideration
offered or paid by the Company to retailers, distributors or end consumers.
Those provisions of these EITF's where consensus was reached by the FASB are
effective for the Company's financial statements at March 1, 2002. The
Company has determined that the impact of adopting these EITF's on the
Company's financial statements is not material. However, the "cost" of
certain sales incentives or consideration previously recognized in the
Company's financial statements as operating expenses will be reclassified as
reductions in net sales and/or increases in cost of goods sold. If the
Company had adopted these EITF's at June 1, 2001, and applied the applicable
provisions retroactively, gross profit for the three months ended August 31,
2001 and 2000 would have decreased by approximately $6.6 million and $5.5
million, respectively, and selling and marketing expenses would have
decreased by like amounts for the respective periods.

     In July 2001, the FASB issued SFAS No. 142, "Goodwill and Other Intangible
Assets," which supercedes APB No. 17, "Intangible Assets." SFAS No. 142
establishes accounting and reporting standards for goodwill and other intangible
assets. SFAS No. 142, which includes the requirements to test goodwill and
intangible assets with indefinite lives for impairment rather than amortize
them, is effective for the Company's financial statements as of June 1, 2002.
The Company has not determined the impact of adopting SFAS No. 142 to the
consolidated financial statements.

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
        OF OPERATIONS

     THE FOLLOWING DISCUSSION AND ANALYSIS SHOULD BE READ IN CONJUNCTION WITH
THE CONSOLIDATED FINANCIAL STATEMENTS, INCLUDING THE NOTES THERETO, APPEARING
ELSEWHERE IN THIS QUARTERLY REPORT ON FORM 10-Q. EXCEPT FOR THE HISTORICAL
INFORMATION CONTAINED HEREIN, THE MATTERS DISCUSSED IN THIS QUARTERLY REPORT
CONTAIN FORWARD-LOOKING STATEMENTS WITHIN THE MEANING OF


                                       9
<Page>

SECTION 27A OF THE SECURITIES ACT OF 1933, AS AMENDED, AND SECTION 21E OF THE
SECURITIES EXCHANGE ACT OF 1934, AS AMENDED, THAT ARE BASED ON MANAGEMENT'S
BELIEFS AND ASSUMPTIONS, CURRENT EXPECTATIONS, ESTIMATES, AND PROJECTIONS.
STATEMENTS THAT ARE NOT HISTORICAL FACTS, INCLUDING WITHOUT LIMITATION
STATEMENTS WHICH ARE PRECEDED BY, FOLLOWED BY OR INCLUDE THE WORDS "BELIEVES,"
"ANTICIPATES," "PLANS," "EXPECTS," "ESTIMATES," "MAY," "SHOULD" OR SIMILAR
EXPRESSIONS ARE FORWARD-LOOKING STATEMENTS. THESE STATEMENTS ARE SUBJECT TO
RISKS AND UNCERTAINTIES, CERTAIN OF WHICH ARE BEYOND THE COMPANY'S CONTROL, AND,
THEREFORE, ACTUAL RESULTS MAY DIFFER MATERIALLY.

     IMPORTANT FACTORS THAT MAY AFFECT FUTURE RESULTS INCLUDE, BUT ARE NOT
LIMITED TO: DEPENDENCE ON INDIVIDUAL PRODUCTS, DEPENDENCE ON INDIVIDUAL
CUSTOMERS, THE IMPACT OF COMPETITIVE PRODUCTS AND PRICING, THE IMPACT OF NEW
FOOD AND DRUG ADMINISTRATION ("FDA") DIETARY SUPPLEMENT REGULATIONS ON THE
COMPANY'S PRODUCTS AND MARKETING PLANS, MARKET AND INDUSTRY CONDITIONS INCLUDING
PRICING, DEMAND FOR PRODUCTS, LEVEL OF TRADE INVENTORIES AND RAW MATERIALS
AVAILABILITY AND PRICING, THE SUCCESS OF PRODUCT DEVELOPMENT AND NEW PRODUCT
INTRODUCTIONS INTO THE MARKETPLACE, CHANGES IN LAWS AND REGULATIONS, LITIGATION
AND GOVERNMENT REGULATORY ACTION, LACK OF AVAILABLE PRODUCT LIABILITY INSURANCE
FOR PRODUCTS CONTAINING EPHEDRA, UNCERTAINTY OF MARKET ACCEPTANCE OF NEW
PRODUCTS, ADVERSE PUBLICITY REGARDING THE CONSUMPTION OF NUTRITIONAL
SUPPLEMENTS, AND OTHER FACTORS DISCUSSED FROM TIME TO TIME IN THE COMPANY'S SEC
REPORTS, COPIES OF WHICH ARE AVAILABLE UPON REQUEST FROM THE COMPANY'S INVESTOR
RELATIONS DEPARTMENT. THE COMPANY DISCLAIMS ANY OBLIGATION TO UPDATE ANY
FORWARD-LOOKING STATEMENTS WHETHER AS A RESULT OF NEW INFORMATION, FUTURE EVENTS
OR OTHERWISE.

GENERAL

     Weider Nutrition International, Inc. (the "Company") develops,
manufactures, markets, distributes and sells branded and private label
nutritional supplements in the United States and throughout the world. The
Company offers a broad range of capsules and tablets, powdered drink mixes,
bottled beverages and nutrition bars consisting of approximately 875 nutritional
supplement stock keeping units ("SKUs") domestically and internationally. The
Company has a portfolio of recognized brands, including Schiff(R), Weider(R),
American Body Building(TM), Tiger's Milk(R), Multipower(R) and Multaben that are
primarily marketed through mass market, health food store and/or health club and
gym distribution channels. The Company markets its branded nutritional
supplement products, both domestically and internationally, in four principal
categories: specialty, vitamins, minerals and herbs; sports nutrition; weight
management; and nutrition bars. The Company also markets a line of sportswear in
Europe, primarily in Germany, under the Venice Beach brand.

     The Company's principal executive offices are located at 2002 South 5070
West, Salt Lake City, Utah 84104 and its telephone number is (801) 975-5000. As
used herein, the "Company" means Weider Nutrition International, Inc. and its
subsidiaries, except where indicated otherwise.

RESULTS OF OPERATIONS (UNAUDITED)
THREE MONTHS ENDED AUGUST 31, 2001 COMPARED TO THREE MONTHS
ENDED AUGUST 31, 2000



                                       10
<Page>


     The following table shows selected items expressed on an actual basis and
as a percentage of net sales for the respective interim periods:

<Table>
<Caption>
                                                                   Three Months Ended August 31,
                                                          ------------------------------------------------
                                                                  2001                       2000
                                                          --------------------       ---------------------
                                                                       (dollars in thousands)

        <S>                                              <C>           <C>          <C>            <C>
         Net sales....................................    $ 87,154      100.0%       $ 91,210       100.0%
         Cost of goods sold...........................      53,954       61.9          53,255        58.4
                                                          --------     ------        --------       -----
         Gross profit.................................      33,200       38.1          37,955        41.6
                                                          --------     ------        --------       -----
         Operating expenses...........................      31,959       36.7          36,030        39.5
         Litigation settlement........................          --         --          (3,571)       (3.9)
         Plant consolidation and
           transition.................................          --         --             648          .7
                                                          --------      -----        --------      ------
         Total operating expenses.....................      31,959       36.7          33,107        36.3
                                                          --------      -----        --------      ------
         Income from operations.......................       1,241        1.4           4,848         5.3
         Other expense, net...........................       2,406        2.7           2,486         2.7
         Income taxes (benefit).......................        (813)       (.9)            398          .4
                                                         ---------      -----        --------        ----
         Net income (loss)............................    $   (352)       (.4)%      $  1,964         2.2%
                                                         =========      =====        ========        ====
</Table>

     NET SALES. Net sales for the three months ended August 31, 2001 decreased
$4.1 million, or 4.4%, to $87.2 million from $91.2 million for the three months
ended August 31, 2000. During the three months ended August 31, 2001, sales to
mass market retailers (including food, drug, mass, club and convenience stores)
and health food store distributors and retailers decreased compared to the three
months ended August 31, 2000, while sales to international markets increased.
Sales to health club and gym distributors were relatively constant for the first
quarter of fiscal 2002 compared to the first quarter of fiscal 2001.

     First quarter fiscal 2002 sales to mass market retailers decreased
approximately 3.0% to $49.7 million from first quarter fiscal 2001 sales of
$51.3 million. The decrease in sales to mass market retailers was primarily the
result of decreased sales to existing accounts of the Company's leading
Schiff(R) Move Free(R) branded product. Net sales of Schiff(R) Move Free(R)
amounted to $25.1 million for the first quarter of fiscal 2002 compared to $31.2
million for the first quarter of fiscal 2001. Sales to health food store
distributors and retailers decreased approximately 55.0% to $2.9 million for the
fiscal 2002 first quarter from $6.4 million for the fiscal 2001 first quarter.
The decrease in sales in the health food distribution channel resulted primarily
from reduced private label sales volume with GNC. Sales to international markets
increased approximately 7.1% to $28.0 million for the three months ended August
31, 2001 from $26.2 million for the three months ended August 31, 2000. The
increased sales volume was primarily due to private label and branded
nutritional supplement sales growth in the Company's European operations.

     GROSS PROFIT. Gross profit decreased approximately 12.5% to $33.2 million
for the quarter ended August 31, 2001 compared to $38.0 million for the quarter
ended August 31, 2000 (See Note 8 to the Condensed Consolidated Financial
Statements). Gross profit, as a percentage of net sales, was 38.1% for the
quarter ended August 31, 2001 compared to 41.6% for the quarter ended August 31,
2000. The decrease in the gross profit percentage resulted primarily from a
significant decrease in gross margins on European sportswear and private label
sales and lower gross margins on increased domestic private label sales.


                                       11
<Page>

     OPERATING EXPENSES. Operating expenses, which included plant consolidation
and transition costs, and litigation settlement income, for the first quarter of
fiscal 2001, decreased approximately 3.5% to $32.0 million for the fiscal 2002
first quarter from $33.1 million for the fiscal 2001 first quarter. During the
fiscal 2001 first quarter the Company completed the consolidation of beverage
manufacturing to its South Carolina facility. In conjunction with the closing of
the Company's Las Vegas, Nevada beverage facility, the Company recognized
approximately $0.6 million in net consolidation and transition related costs.
Also, during the first quarter of fiscal 2001, the Company received $3.6 million
from the settlement of litigation. Excluding the effects of these unusual items,
operating expenses decreased $4.1 million, or 11.3% during the first quarter of
fiscal 2002 in comparison to the first quarter of fiscal 2001. The decrease
resulted primarily from reductions in international selling and marketing
expenses and from reductions in domestic personnel costs as well as other
general and administrative related savings.

     Selling and marketing expenses, including sales, marketing, advertising,
freight and other costs, decreased approximately 10.1% to $23.1 million for the
fiscal 2002 first quarter from $25.7 million for the fiscal 2001 first quarter.
The decrease in selling and marketing expenses resulted primarily from decreased
promotional costs in the Company's international operations and was impacted by
expenses in the prior year quarter associated with the product name transition
of the Company's Schiff(R) Move Free(R) brand.

     General and administrative expenses decreased approximately 16.1% to
$6.7 million for the quarter ended August 31, 2001 from $8.0 million for the
quarter ended August 31, 2000. The decrease in general and administrative
expenses for the first quarter of fiscal 2002 resulted primarily from a
decrease in outside professional and personnel related costs as well as
reductions in legal related costs.

     OTHER EXPENSE. Other expense, net, remained relatively constant at $2.4
million for the quarter ended August 31, 2001, compared to $2.5 million for the
quarter ended August 31, 2000. Reductions in net interest cost, associated with
a lower overall effective borrowing rate, were partially offset by an increase
in other non-operating costs. The increase in other non-operating costs was
primarily attributable to provisions for potentially uncollectible notes
receivable.

     PROVISION FOR INCOME TAXES. Provision for income taxes amounted to a $0.8
million benefit for the quarter ended August 31, 2001 compared to a $0.4 million
expense for the quarter ended August 31, 2000. The change resulted primarily
from the decrease in pre-tax earnings and the net effect of tax rate differences
for the Company's domestic and international operations.

     LIQUIDITY AND CAPITAL RESOURCES. The Company's working capital remained
relatively constant, amounting to approximately $45.6 million and $45.3 million,
respectively, at August 31, 2001 and May 31, 2001.

     The Company and its domestic subsidiaries have a $90.0 million senior
credit facility (the "Credit Facility") with Bankers Trust Company. The Credit
Facility is comprised of a $30.0 million term loan and a $60.0 million revolving
loan. Under the revolving loan, the Company may borrow up to the lesser of $60.0
million or the sum of (i) 85% of eligible accounts receivable and (ii) the
lesser of $30.0 million or 65% of the eligible inventory. The Credit Facility
contains customary terms and conditions, including, among


                                       12
<Page>

others, financial covenants regarding minimum cash flows and limitations on
indebtedness and the Company's ability to pay dividends under certain
circumstances. The obligations of the Company under the Credit Facility are
secured by a first priority lien on all owned or acquired tangible and
intangible assets of the Company and its domestic subsidiaries. The Credit
Facility is being used to fund the normal working capital and capital
expenditure requirements of the Company. At August 31, 2001, the Company had
approximately $13.3 million in available revolving loan funds.

     The Company's domestic operations are also supported by a $10.0 million
senior subordinated loan agreement (the "Subordinated Loan"). The Subordinated
Loan contains customary terms and conditions, including, among others, financial
covenants regarding minimum cash flows and limitations on indebtedness and the
Company's ability to pay dividends under certain circumstances.

     The Company's international operations (primarily Haleko) are supported by
an approximate $17.9 million Germany based secured credit facility. This credit
facility is a revolving loan that renews annually.

     The Company expects to fund its long-term capital requirements for the next
twelve months through the use of operating cash flow supplemented as necessary
by borrowings under both the domestic Credit Facility and Haleko's credit
facility. The Company also from time to time may evaluate strategic acquisitions
as the nutritional supplements industry continues to consolidate. The funding of
future acquisitions, if any, may require other debt financing or the issuance of
additional equity.

     The Company paid a quarterly dividend of $0.0375 per share subsequent to
August 31, 2001. The dividend was declared to be payable on September 20, 2001
to holders of all classes of common stock of record at the close of business on
September 11, 2001. The Company's Board of Directors will determine dividend
policy in the future based upon, among other things, the Company's results of
operations, financial condition, contractual restrictions and other factors
deemed relevant at the time. The Credit Facility contains certain customary
financial covenants that may limit the Company's ability to pay dividends on its
common stock. Accordingly, there can be no assurance that the Company will pay
dividends in the future.

     IMPACT OF INFLATION. The Company has historically been able to pass
inflationary increases for raw materials and other costs through to its
customers and anticipates that it will be able to continue to do so in the
future. However, there can be no assurance that the Company will be able to pass
inflationary increases on to its customers.

     SEASONALITY. The Company's business is seasonal, with lower sales typically
realized during the first and second fiscal quarters and higher sales typically
realized during the third and fourth fiscal quarters. The Company believes such
fluctuations in sales are the result of greater marketing and promotional
activities toward the end of each fiscal year, customer buying patterns,
including seasonal sportswear considerations, and consumer spending patterns
related primarily to the consumers' interest in achieving personal health and
fitness goals after the beginning of each new calendar year and before the
summer fashion season.

     Furthermore, as a result of changes in product sales mix and other factors,
as discussed above, the Company experiences fluctuations in gross profit and
operating margins on a quarter-to-quarter basis.


                                       13
<Page>

ITEM 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

     The following discussion involves forward-looking statements of market risk
which assume for analytical purposes that certain adverse market conditions may
occur. Actual future market conditions may differ materially from such
assumptions. Accordingly, the forward-looking statements should not be
considered projections by the Company of future events or losses.

     The Company's cash flows and net earnings are subject to fluctuations
resulting from changes in interest rates and foreign exchange rates. The Company
currently is not party to any significant derivative instruments and its current
policy does not allow speculation in derivative instruments for profit or
execution of derivative instrument contracts for which there are no underlying
exposure. The Company does not use financial instruments for trading purposes.

     The Company measures its market risk, related to its holdings of financial
instruments, based on changes in interest rates utilizing a sensitivity
analysis. The Company does not believe that a hypothetical 10% change in
interest rates would have a material effect on the Company's pretax earnings or
cash flows.

PART II. OTHER INFORMATION

ITEM 1.  LEGAL PROCEEDINGS.

     The information set forth in Note 7 to Condensed Consolidated Financial
Statements in Item 1 of this Quarterly Report on Form 10-Q is incorporated
herein by reference.

ITEM 2.  CHANGES IN SECURITIES.

         Not applicable.

ITEM 3.  DEFAULTS UPON SENIOR SECURITIES.

         Not applicable.


ITEM 4.  SUBMISSION OF MATTER TO A VOTE OF SECURITY HOLDERS.

         Not applicable.

ITEM 5.  OTHER INFORMATION.

         Not applicable.

ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K

         (a)  Exhibits:

2.1      Stock Purchase Agreement, dated July 9, 1998, by and among Weider
         Nutrition Group, Inc. and Wolfgang Brandt and Eberhardt Schl ter. (2)
2.2      Amendment Deed to Stock Purchase Agreement, dated July 24, 1998. (2)
2.3      Share Transfer Deed, dated July 24, 1998. (2)
3.1      Amended and Restated Certificate of Incorporation of Weider Nutrition
         International, Inc. (1)
3.2      Amended and Restated Bylaws of Weider Nutrition International, Inc. (1)


                                       14
<Page>

4.1      Credit Agreement dated as of June 30, 2000 among Weider Nutrition
         International, Inc. and Bankers Trust Company. (4)
4.2      Senior Subordinated Loan Agreement dated as of June 30, 2000 among
         Weider Nutrition International, Inc.,
         Wynnchurch Capital Partners, L.P., and Wynnchurch Capital Partners
         Canada, L.P. (4)
4.3      Warrants to Purchase Shares of Class A Common Stock of Weider Nutrition
         International, Inc. (4)
4.4      Registration Rights Agreement dated as of June 30, 2000 among Weider
         Nutrition International, Inc., Wynnchurch Capital Partners, L.P. and
         Wynnchurch Capital Partners Canada, L.P. (4)
4.5      First Amendment to Credit Agreement dated as of June 30, 2000 among
         Weider Nutrition International, Inc. and Bankers Trust Company. (5)
4.6      First Amendment to Senior Subordinated Loan Agreement dated as of
         June 30, 2000 among Weider Nutrition International, Inc., Wynnchurch
         Capital Partners, L.P. and Wynnchurch Capital Partners Canada, L.P. (7)
4.7      Second Amendment to Credit Agreement dated as of June 30, 2000 among
         Weider Nutrition International, Inc. and Bankers Trust Company. (8)
4.8      Second Amendment to Senior Subordinated Loan Agreement dated as of
         June 30. 2000 among Weider Nutrition International, Inc., Wynnchurch
         Capital Partners, L.P. and Wynnchurch Capital Partners Canada, L.P. (8)
10.1     Build-To-Suit Lease Agreement, dated March 20, 1996, between SCI
         Development Services Incorporated and Weider Nutrition Group, Inc. (1)
10.2     Agreement by and between Joseph Weider and Weider Health and
         Fitness. (1)
10.3     1997 Equity Participation Plan of Weider Nutrition International,
         Inc. (1)
10.4     Form of Tax Sharing Agreement by and among Weider Nutrition
         International, Inc. and its subsidiaries and Weider Health and Fitness
         and its subsidiaries. (1)
10.6     Form of Employment Agreement between Weider Nutrition International,
         Inc. and Robert K. Reynolds, as amended. (5)
10.7     Form of Senior Executive Employment Agreement between Weider Nutrition
         International, Inc. and certain senior executives of the Company. (1)
10.8     Advertising Agreement between Weider Nutrition International, Inc. and
         Weider Publications, Inc. (1)
10.9     License Agreement between Mariz Gestao E Investmentos Limitada and
         Weider Nutrition Group Limited. (1)
10.10    Form of Employment Agreement between Weider Nutrition International,
         Inc. and  Bruce J. Wood. (3)
10.11    Agreement between the Company and Bruce J. Wood. (6)
10.12    Form Agreement between the Company and certain executives of the
         Company. (6)
10.13    Third Amendment to 1997 Equity Participation Plan of Weider Nutrition
         International, Inc. (9)
21       Subsidiaries of Weider Nutrition International, Inc. (8)
-------------------------------------------------------

(1)      Filed as an Exhibit to the Company's Registration Statement on Form
         S-1 (File No. 333-12929) and incorporated herein by reference.
(2)      Previously filed in the Company's Current Report on Form 8-K dated
         as of July 24, 1998 and incorporated herein by reference.
(3)      Previously filed in the Company's Current Report on Form 10-K dated as
         of August 30, 1999 and incorporated herein by reference.
(4)      Previously filed in the Company's Current Report on Form 8-K dated as
         of June 30, 2000 and incorporated herein by reference.
(5)      Previously filed in the Company's Current Report on Form 10-K as of
         August 29, 2000 and incorporated herein by reference.
(6)      Previously filed in the Company's Current Report on Form 10-K/A as of
         September 28, 2000 and incorporated herein by reference.
(7)      Previously filed in the Company's Current Report on Form 10-Q as of
         January 15, 2001 and incorporated herein by reference.
(8)      Previously filed in the Company's Current Report on Form 10-K as of
         August 29, 2001 and incorporated herein by reference.
(9)      Filed herewith.

         (b)  Reports on Form 8-K

         None


                                       15
<Page>


                                   SIGNATURES



     Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.

                                       WEIDER NUTRITION INTERNATIONAL, INC.



Date: October 15, 2001                 By: /s/ Bruce J. Wood
                                           ---------------------------------
                                                   Bruce J. Wood
                                       President, Chief Executive Officer
                                                    and Director



Date: October 15, 2001                 By: /s/ Joseph W. Baty
                                           ----------------------------------
                                                     Joseph W. Baty
                                              Executive Vice President and
                                                Chief Financial Officer





                                       16